Advanced Oncotherapy (AVO) has reported continued progress in the development of its next-generation proton beam therapy system, LIGHT, despite the challenges of the Covid-19 pandemic. Announcing its results for the six months ended 30 June 2020, CEO Nicolas Serandour said activities had resumed at the Daresbury site and are expected to be in line with…
Membership Required
You must be a HM Subscriber to view this content.
Already have an account? Sign In
©2025 All rights reserved LaingBuisson 
 has reported continued progress in the development of its next-generation proton beam therapy system, LIGHT, despite the challenges of the Covid-19 pandemic.){kind=link}